WFH 2025: Safety and Efficacy of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of Phase 1/2 Study

April 23, 2025
July 22, 2025

Presented at WFH 2025 Comprehensive Care Summit: New Developments in Bleeding Disorders and MSK

To view the presentation, click here